See more : Cars.com Inc. (CARS) Income Statement Analysis – Financial Results
Complete financial analysis of Walgreens Boots Alliance, Inc. (WBA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Walgreens Boots Alliance, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Orphazyme A/S (ORPHA.CO) Income Statement Analysis – Financial Results
- ECOVE Environment Corp. (6803.TWO) Income Statement Analysis – Financial Results
- Big Lots, Inc. (BIG) Income Statement Analysis – Financial Results
- Indo Count Industries Limited (ICIL.BO) Income Statement Analysis – Financial Results
- Ningbo David Medical Device Co., Ltd. (300314.SZ) Income Statement Analysis – Financial Results
Walgreens Boots Alliance, Inc. (WBA)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 147.66B | 139.08B | 132.70B | 132.51B | 121.98B | 120.07B | 131.54B | 118.21B | 117.35B | 103.44B | 76.39B | 72.22B | 71.63B | 72.18B | 67.42B | 63.34B | 59.03B | 53.76B | 47.41B | 42.20B | 37.51B | 32.51B | 28.68B | 24.62B | 21.21B | 17.84B | 15.31B | 13.36B | 11.78B | 10.40B | 9.24B | 8.29B | 7.48B | 6.73B | 6.05B | 5.38B | 4.88B | 4.28B | 3.66B | 3.16B |
| Cost of Revenue | 121.13B | 112.01B | 104.44B | 104.44B | 95.91B | 91.92B | 100.75B | 89.05B | 87.48B | 76.59B | 54.82B | 51.10B | 51.29B | 51.69B | 48.44B | 45.72B | 42.39B | 38.52B | 34.24B | 30.41B | 27.31B | 23.71B | 21.08B | 18.05B | 15.24B | 12.77B | 10.95B | 9.52B | 8.37B | 7.35B | 6.50B | 5.85B | 5.29B | 4.74B | 4.29B | 3.78B | 3.41B | 2.95B | 2.51B | 2.16B |
| Gross Profit | 26.52B | 27.07B | 28.27B | 28.07B | 26.08B | 28.16B | 30.79B | 29.16B | 29.87B | 26.86B | 21.57B | 21.12B | 20.34B | 20.49B | 18.98B | 17.61B | 16.64B | 15.24B | 13.17B | 11.79B | 10.20B | 8.80B | 7.61B | 6.57B | 5.97B | 5.07B | 4.36B | 3.85B | 3.41B | 3.04B | 2.74B | 2.44B | 2.19B | 1.99B | 1.76B | 1.60B | 1.47B | 1.33B | 1.15B | 1.00B |
| Gross Profit Ratio | 17.96% | 19.46% | 21.30% | 21.18% | 21.38% | 23.45% | 23.41% | 24.67% | 25.46% | 25.96% | 28.23% | 29.24% | 28.40% | 28.39% | 28.15% | 27.81% | 28.19% | 28.35% | 27.78% | 27.93% | 27.19% | 27.07% | 26.52% | 26.70% | 28.16% | 28.42% | 28.46% | 28.77% | 28.96% | 29.29% | 29.66% | 29.42% | 29.29% | 29.53% | 29.13% | 29.65% | 30.18% | 31.16% | 31.54% | 31.75% |
| Research & Development | 0.00 | 371.00M | 307.00M | 284.00M | 300.00M | 260.00M | 254.00M | 245.00M | 238.00M | 178.00M | 127.00M | 105.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.62B | 24.70B | 24.13B | 23.03B | 22.30B | 22.60B | 23.97B | 23.05B | 22.83B | 21.18B | 17.43B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 694.00M | 775.00M | 862.00M | 772.00M | 532.00M | 582.00M | 665.00M | 571.00M | 598.00M | 491.00M | 265.00M | 286.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.11B | 25.48B | 24.99B | 23.80B | 22.84B | 23.18B | 24.64B | 23.62B | 23.43B | 21.67B | 17.69B | 17.47B | 16.88B | 16.56B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.52B | 3.84B | 3.33B | 2.97B | 2.66B | 2.39B | 2.16B | 1.93B | 1.74B | 1.58B | 1.41B | 1.28B | 1.19B | 1.07B | 914.00M | 791.70M |
| Other Expenses | 0.00 | 8.10B | 1.58B | 1.64B | 1.96B | -50.00M | -389.00M | -185.00M | 210.00M | 344.00M | -443.00M | 0.00 | 0.00 | -434.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| Operating Expenses | 40.60B | 33.95B | 26.88B | 25.73B | 25.10B | 23.39B | 24.50B | 23.68B | 23.87B | 22.19B | 17.38B | 16.98B | 16.88B | 16.13B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.75B | 4.05B | 3.52B | 3.14B | 2.81B | 2.52B | 2.28B | 2.03B | 1.83B | 1.67B | 1.48B | 1.34B | 1.25B | 1.12B | 957.80M | 826.10M |
| Cost & Expenses | 161.73B | 145.96B | 131.32B | 130.17B | 121.00B | 115.31B | 125.25B | 112.73B | 111.35B | 98.78B | 72.20B | 68.08B | 68.17B | 67.82B | 63.96B | 60.09B | 55.59B | 50.61B | 44.71B | 39.78B | 35.37B | 30.66B | 27.06B | 23.22B | 19.98B | 16.82B | 14.47B | 12.66B | 11.17B | 9.88B | 8.78B | 7.89B | 7.12B | 6.41B | 5.76B | 5.13B | 4.66B | 4.07B | 3.46B | 2.98B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 29.00M | 0.00 | 0.00 | 0.00 | 0.00 | 134.00M | 0.00 | 95.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 482.00M | 580.00M | 396.00M | 491.00M | 613.00M | 650.00M | 616.00M | 693.00M | 596.00M | 605.00M | 156.00M | 165.00M | 88.00M | 71.00M | 85.00M | 83.00M | 11.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.46B | 1.89B | 1.68B | 1.69B | 1.63B | 1.78B | 1.52B | 1.41B | 1.48B | 1.56B | 1.21B | 1.18B | 1.17B | 1.09B | 1.03B | 975.00M | 840.00M | 675.90M | 572.20M | 482.10M | 403.10M | 346.10M | 307.30M | 269.20M | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| EBITDA | -11.28B | 3.48B | 4.96B | 5.96B | 2.84B | 6.75B | 7.67B | 6.95B | 7.93B | 6.75B | 5.08B | 5.34B | 4.63B | 5.45B | 4.49B | 4.22B | 4.28B | 3.83B | 3.27B | 2.91B | 2.55B | 2.21B | 1.93B | 1.67B | 1.45B | 1.23B | 1.02B | 872.60M | 751.40M | 651.60M | 573.80M | 510.90M | 450.60M | 405.50M | 354.60M | 317.30M | 283.60M | 264.40M | 240.40M | 212.20M |
| EBITDA Ratio | -7.64% | -1.86% | 4.80% | 4.12% | 2.37% | 5.31% | 6.36% | 6.09% | 6.36% | 7.40% | 6.58% | 7.37% | 6.46% | 7.55% | 6.66% | 6.67% | 7.25% | 7.12% | 6.91% | 6.89% | 6.74% | 6.66% | 6.71% | 6.68% | 6.70% | 6.87% | 6.45% | 6.48% | 6.34% | 6.22% | 6.15% | 6.16% | 5.89% | 5.89% | 5.61% | 5.73% | 5.72% | 6.15% | 6.51% | 6.65% |
| Operating Income | -14.08B | -6.88B | 1.39B | 2.34B | 982.00M | 4.77B | 6.29B | 5.48B | 6.00B | 4.67B | 4.19B | 3.65B | 3.46B | 4.37B | 3.46B | 3.25B | 3.44B | 3.15B | 2.70B | 2.42B | 2.14B | 1.85B | 1.62B | 1.40B | 1.22B | 1.02B | 835.00M | 708.00M | 604.10M | 520.10M | 455.70M | 406.20M | 358.50M | 321.20M | 284.20M | 253.50M | 224.20M | 210.70M | 196.60M | 177.80M |
| Operating Income Ratio | -9.53% | -4.95% | 1.05% | 1.77% | 0.81% | 3.97% | 4.78% | 4.64% | 5.11% | 4.51% | 5.49% | 5.05% | 4.84% | 6.05% | 5.13% | 5.13% | 5.83% | 5.86% | 5.70% | 5.74% | 5.71% | 5.69% | 5.66% | 5.68% | 5.77% | 5.69% | 5.46% | 5.30% | 5.13% | 5.00% | 4.93% | 4.90% | 4.80% | 4.77% | 4.70% | 4.71% | 4.59% | 4.92% | 5.37% | 5.62% |
| Total Other Income/Expenses | -126.00M | 1.46B | 2.65B | 280.00M | -505.00M | -399.00M | -260.00M | -623.00M | -813.00M | 667.00M | -637.00M | -45.00M | -88.00M | -71.00M | -85.00M | -83.00M | -11.00M | 28.80M | 52.60M | -11.30M | 17.00M | 23.40M | 13.10M | 24.40M | 39.20M | 11.90M | 42.10M | 4.60M | 2.80M | 3.70M | 2.70M | -6.50M | -5.50M | -9.20M | -3.30M | -9.70M | -15.20M | -16.60M | -9.00M | -4.10M |
| Income Before Tax | -14.20B | -5.39B | 4.04B | 2.62B | 477.00M | 4.37B | 6.03B | 4.86B | 5.19B | 5.34B | 3.56B | 4.05B | 3.38B | 4.29B | 3.37B | 3.16B | 3.43B | 3.19B | 2.75B | 2.46B | 2.18B | 1.89B | 1.64B | 1.42B | 1.26B | 1.03B | 877.00M | 712.00M | 606.90M | 523.80M | 458.40M | 399.70M | 353.00M | 312.00M | 280.90M | 243.80M | 209.00M | 194.10M | 187.60M | 173.70M |
| Income Before Tax Ratio | -9.62% | -3.87% | 3.04% | 1.98% | 0.39% | 3.64% | 4.58% | 4.11% | 4.42% | 5.16% | 4.66% | 5.60% | 4.71% | 5.95% | 5.00% | 5.00% | 5.81% | 5.93% | 5.81% | 5.82% | 5.80% | 5.81% | 5.71% | 5.78% | 5.96% | 5.76% | 5.73% | 5.33% | 5.15% | 5.04% | 4.96% | 4.82% | 4.72% | 4.63% | 4.64% | 4.53% | 4.28% | 4.53% | 5.12% | 5.49% |
| Income Tax Expense | 1.25B | 1.86B | 30.00M | 667.00M | 339.00M | 577.00M | 998.00M | 760.00M | 997.00M | 1.06B | 1.53B | 1.50B | 1.25B | 1.58B | 1.28B | 1.16B | 1.27B | 1.15B | 1.00B | 896.10M | 816.10M | 713.00M | 618.10M | 537.10M | 486.40M | 403.20M | 340.00M | 276.00M | 235.20M | 203.00M | 176.50M | 154.40M | 132.40M | 117.00M | 106.30M | 89.60M | 79.90M | 90.60M | 84.50M | 79.50M |
| Net Income | -8.64B | -3.08B | 4.34B | 2.54B | 456.00M | 3.98B | 5.02B | 4.08B | 4.17B | 4.22B | 1.93B | 2.55B | 2.13B | 2.71B | 2.09B | 2.01B | 2.16B | 2.04B | 1.75B | 1.56B | 1.36B | 1.18B | 1.02B | 885.60M | 776.90M | 624.10M | 511.00M | 436.00M | 371.70M | 320.80M | 281.90M | 221.70M | 220.60M | 195.00M | 174.60M | 154.20M | 129.10M | 103.50M | 103.10M | 94.20M |
| Net Income Ratio | -5.85% | -2.21% | 3.27% | 1.92% | 0.37% | 3.32% | 3.82% | 3.45% | 3.56% | 4.08% | 2.53% | 3.53% | 2.97% | 3.76% | 3.10% | 3.17% | 3.65% | 3.80% | 3.69% | 3.70% | 3.63% | 3.62% | 3.55% | 3.60% | 3.66% | 3.50% | 3.34% | 3.26% | 3.16% | 3.09% | 3.05% | 2.67% | 2.95% | 2.90% | 2.89% | 2.87% | 2.64% | 2.42% | 2.82% | 2.98% |
| EPS | -10.01 | -3.57 | 5.02 | 2.31 | 0.20 | 4.14 | 5.07 | 3.80 | 3.85 | 4.05 | 2.03 | 2.69 | 2.43 | 2.97 | 2.13 | 2.03 | 2.18 | 2.04 | 1.73 | 1.53 | 1.32 | 1.14 | 1.00 | 0.87 | 0.77 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | -10.01 | -3.57 | 5.01 | 2.30 | 0.20 | 4.13 | 5.05 | 3.78 | 3.82 | 4.00 | 2.00 | 2.67 | 2.42 | 2.94 | 2.12 | 2.02 | 2.17 | 2.03 | 1.72 | 1.52 | 1.31 | 1.13 | 0.99 | 0.86 | 0.76 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 863.10M | 863.20M | 864.40M | 864.80M | 879.40M | 921.50M | 991.00M | 1.07B | 1.08B | 1.04B | 953.10M | 946.00M | 874.70M | 915.10M | 981.70M | 990.00M | 990.61M | 998.63M | 1.01B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.01B | 1.00B | 1.98B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
| Weighted Avg Shares Out (Dil) | 863.10M | 863.20M | 865.90M | 866.40M | 880.30M | 923.50M | 995.00M | 1.08B | 1.09B | 1.05B | 965.20M | 955.20M | 880.10M | 924.50M | 987.90M | 991.30M | 995.54M | 1.01B | 1.02B | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B | 1.02B | 1.01B | 2.01B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
Walgreens Stock Slides as Analysts Question Store-Closure Impact
Shares of pharmacy giant Walgreens Boots Alliance (WBA) tumbled on Tuesday after investment bank TD Cowen cut its price target on the stock to $14 from $16.
Why Walgreens Boots Alliance Plunged Again Today
The stock couldn't hold on to its post-earnings rally, as the threat of online competition came to the fore again.
Walgreens and Dion's Chicago Dream Join Forces to Host a Dream Vault Smart Locker in Gage Park Store
The Dream Vault will provide free, high-quality produce to more than 175 local households per week CHICAGO , Oct. 22, 2024 /PRNewswire/ -- To improve health equity and food security in the Chicago market, Walgreens is joining forces with non-profit Dion's...
Walgreens Collects More than 6-Million Pounds of Unused Prescription Medication, Seeks the Public's Help for National Drug Takeback Day
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is calling on the public to help in the fight against prescription drug abuse by taking part in National Prescription Drug Takeback Day on Saturday, October 26th, 2024. Twice a year, drug takeback days are reserved for...
These 15 Stocks Are Among the Top Dividend Payers on the NASDAQ
24/7 Wall Street Insights NASDAQ was founded in 1971 as an automated quote stock exchange alternative to the New York Stock Exchange, and now has more listings than the NYSE.
Walmart will start delivering prescriptions to customers' doorsteps as CVS and Walgreens struggle
Walmart said Tuesday that it will start delivering prescriptions to customers' doorsteps. The discounter will start with six states, but plans to offer prescription delivery in 49 states by the end of January.
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Walgreens Boots Alliance Inc. NASDAQ: WBA is a leading global retail pharmacy and healthcare company. The stock is trading down 60% from its 52-week high and with a stock performance down 58.5% year-to-date (YTD).
Is Walgreens' Ultra-High-Yield Dividend in Jeopardy Again?
Income investors, beware.
These Are the 5 Most Shorted Stocks in the S&P 500 Index. The Bears Are Wrong About 1 of Them.
Investors "short" stocks that they think will fall in price, profiting off the loss using a sometimes risky buying maneuver.
Walgreens: Latest Financials Aren't Comforting Enough
Walgreens Boots Alliance's recent results have sparked investor optimism, providing a lifeline to the sagging stock. The upside sales surprise in Q4 FY24 worked in WBA's favor, but the guidance indicates that sales will remain muted in FY25. The EPS...
Source: https://incomestatements.info
Category: Stock Reports